Business Wire

OR-RADISYS

Share
ContactMakers Selects Radisys Engage Media Server to Power Cloud-Based Customer Interaction Suite

Radisys® Corporation , a global leader of open telecom solutions, today announced that ContactMakers , a contact center telephony solutions and customer care provider, has selected Radisys Engage Media Server as the foundation for its VOIP Communication ContactSuite platform as it moves the solution to the cloud. The Engage Media Server’s extensive flexible capabilities enable ContactMakers to focus its resources to add unique applications, enhanced user experience and custom capabilities for its unique customer interaction suite, rather than on the communications infrastructure. ContactMakers will be able to use the media server to address specific customer requirements more quickly, while reducing costs and complexity by utilizing a common media processing platform for advanced voice, video, media analytics, and other capabilities for its customer offerings.

Highlights

  • Customer contact is always critical to business. Despite the evolution and expansion of communication channels including the internet, text messaging and social media, telecommunications access solutions like business VOIP, mobile and landlines continue to anchor a high volume of interactions including the most critical customer care interactions.
  • With today’s fluid workforce, dynamic global conditions and a growing trend toward remote customer interactions, having a reliable media foundation for real-time voice and video sessions is more critical than ever. To meet this challenge, businesses need a contact center solution that enables them to bring new, scalable and elastic services online more quickly and that can be adapted to changing market conditions more easily than existing off-the-shelf Customer Communication-as-a-Service (CCaaS) products.
  • ContactMakers is undertaking a telco-to-the-cloud migration of its proprietary communications application and interaction platform which it has built and optimized for clients’ customer communication requirements for more than 15 years. Leveraging Radisys Engage Media Server’s cloud-native platform, ContactMakers will be able to lower the cost of migration, deliver greater flexibility, and provide optimal resource utilization.
  • ContactMakers will use the Engage Media Server to deliver telco-grade reliability, video, speech processing, biometrics, and high-quality voice capabilities as the anchor for its service platform.
  • Radisys Engage Media Server is the industry’s leading real-time media processing platform that provides voice, video, and AI-based media, delivering a complete solution set for developers, CCaaS providers and Communications Service Providers (CSP) to create a wholistic digital customer engagement experience.
  • Customer Care, Unified Communications (UC) and CCaaS providers, including OEM and managed service providers alike, depend on Radisys for high quality, cloud-based media processing that can meet dynamic customer, market, and employee conditions, while providing a future-proof, market leading solutions including:
    • Cloud scalability for broader market reach for digital experience applications and services at attractive price points
    • Highest quality voice and video processing
    • Support for VOIP, mobile and landline customer and employee connections
    • Telco-grade reliability to ensure “always on” communications

“We have had a long relationship with Radisys to deliver high-quality communication services that our customers expect. Now, with Radisys’ help, we are able to seamlessly transition to a software environment that can run in our private data center or in the cloud,” said Denise Konings, CEO, ContactMakers. “The combination of Radisys technology, its consultative expertise in the rapidly evolving communications and mobile technology domain, and its world-class global support make Radisys not only a technology supplier, but our key partner in delivering high quality, engaging, customer interactions.”

“Reliable, scalable and cloud-based media processing is the foundation for delivering memorable customer interactions,” said Shankar Krishnamurthy, Radisys’ Senior Director, Business Development. “Engage Media Server is enabling ContactMakers to migrate its services to the cloud to better manage communication workflows, improve the user experience, and track critical customer and employee key performance indicators. It also allows ContactMakers to continue to focus its specialized resources and development budget on service applications.”

About Radisys

Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio from digital end points, to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com .

About ContactMakers

ContactMakers facilitates and realizes top-level telephony for companies that go for quality in customer service. Superior communication technology in the cloud combined with people skills, passion and drive. ContactMakers inspires and challenges you to make every customer contact moment the best that it can be. Together we'll optimize every phase of the customer experience cycle. Visit www.contactmakers.nl for more information.

Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TRU Simulation’s Bell 525 Flight Simulator Receives FAA Interim Level C Qualification17.11.2025 09:00:00 CET | Press release

TRU Simulation + Training Inc., a Textron Inc. (NYSE:TXT) company, and an affiliate of Textron Aviation Inc. and Bell Textron Inc. today announced its Bell 525 Full Flight Simulator (FFS) located at the Bell Training Academy received Interim Level C qualification from the Federal Aviation Administration (FAA). Bell Textron Inc. has designed and will manufacture the Bell 525 helicopter. By achieving this milestone, pilots can earn more flight hours on the Bell 525 platform ahead of the rotorcraft’s expected FAA type certification. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117520706/en/ TRU Simulation’s Bell 525 Flight Simulator receives FAA Interim Level C qualification “The accuracy and realism of our Flight Simulation Devices play a crucial role in ensuring that pilots can effectively translate their training into real-world scenarios,” said Jerry Messaris, vice president and general manager, TRU Simulation. “This q

Polpharma Biologics Confirms U.S. Launch of Tyruko® (natalizumab), the First and Only Biosimilar for Multiple Sclerosis17.11.2025 08:52:00 CET | Press release

Polpharma Biologics, a biopharmaceutical company group focused on biosimilars development and manufacturing, today confirmed that Sandoz Tyruko® (natalizumab-sztn) is now available to patients in the United States. Tyruko® is the first and only FDA-approved biosimilar of natalizumab for the treatment of relapsing forms of multiple sclerosis (MS), and also for adult patients with moderately to severely active Crohn’s disease1. Tyruko® was developed by Polpharma Biologics and will be commercialized in the U.S. by its collaboration partner Sandoz, under an exclusive global license agreement. The launch marks a significant milestone in expanding access to high-quality, affordable treatment options for patients living with MS and Crohn’s disease in the United States. Emmanuelle Lepine, Chair of the Supervisory Board, Polpharma Biologics, commented: "The U.S. launch of Tyruko® marks a pivotal moment not only for Polpharma Biologics, but for patients across the United States. This milestone r

Lone Star Acquires Multi-Asset Real Estate Portfolio from St. James’s Place17.11.2025 08:01:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has successfully completed the acquisition of a multi-asset real estate portfolio from St. James’s Place (SJP) and its Property Unit Trust and Life and Pensions Trust. SJP was advised by Invesco Real Estate, the global real estate investment manager, on the sale of the portfolio. The portfolio comprises 16 high-quality assets across the UK, including multi-let industrial (“MLI”), retail, and office properties. The largest component is the MLI portfolio, which consists of 10 separate property assets predominantly located in Greater London and South East England, and offering access to major transportation and industrial hubs — making them highly attractive for last-mile delivery and regional distribution. The office properties are all situated in London, while the retail assets consist of high-quality retail warehouses with strong tenant bases. Lone Star will implement an active asset

Bureau Veritas appoints Santiago Arias Duval as Executive Vice-President for the Americas region17.11.2025 08:00:00 CET | Press release

Bureau Veritas, a global leader in Testing, Inspection and Certification (TIC), is pleased to announce the appointment of Santiago Arias Duval, effective November 17th, 2025, as Executive Vice-President, Americas. This appointment is in line with Bureau Veritas’ new operating model effective since September 1st, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251116192035/en/ Hinda Gharbi, CEO at Bureau Veritas Bureau Veritas is evolving the structure of its executive committee to drive greater organizational alignment. This organization will empower the regions with scalable Product Lines, enabling global solutions development, and will be unlocking wider cross-selling opportunities. The Americas region is created to leverage fast developing market opportunities across countries in North, Central and South America. This is a dynamic region for all Bureau Veritas where the group intends to expand its leadership across p

Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)17.11.2025 07:00:00 CET | Press release

Pending the European Commission decision, Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide will represent an important new therapeutic option from second line for patients with follicular lymphoma (FL) in EuropeIn Western countries, relapsed or refractory FL affects 2-4 out of every 100,000 people1The positive Committee for Medicinal Products for Human Use (CHMP) recommendation is based on data from the Phase 3 inMIND trial which showed patients with relapsed or refractory FL achieved significantly improved progression-free survival with Minjuvi in combination with rituximab and lenalidomide2 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) (Grade 1-3a) after at

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye